An improved, scalable synthesis of the selective serotonin 2A receptor agonist 25CN-NBOH

Emil Marcher-Rørsted; Jitka Nykodemova; Jesper Langgaard Kristensen

doi:10.1055/a-1524-4439

An improved, scalable synthesis of the selective serotonin 2A receptor agonist 25CN-NBOH

Emil Marcher-Rørsted, Jitka Nykodemova, Jesper Langgaard Kristensen^*

^*Corresponding author af dette arbejde

Medicinalkemi

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2 Citationer (Scopus)

68 Downloads (Pure)

Abstract

4-{2-[(2-hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile (25CN-NBOH) was first reported as a potent and highly selective serotonin 2A receptor (5-HT2AR) agonist in 2014. The compound has since found extensive use as a pharmacological tool in a variety of in vivo and in vitro studies. In the present study, we present an improved and scalable synthesis of 25CN-NBOH making this compound readily available to the scientific community.

Originalsprog	Engelsk
Tidsskrift	SynOpen
Vol/bind	5
Udgave nummer	2
Sider (fra-til)	158-160
DOI	https://doi.org/10.1055/a-1524-4439
Status	Udgivet - 2021

Adgang til dokumentet

10.1055/a-1524-4439Licens: CC BY-NC-ND

FulltextForlagets udgivne version, 315 KBLicens: CC BY-NC-ND

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{c0ef7740c8f243d4957f30859dc078c8,

title = "An improved, scalable synthesis of the selective serotonin 2A receptor agonist 25CN-NBOH",

abstract = "4-{2-[(2-hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile (25CN-NBOH) was first reported as a potent and highly selective serotonin 2A receptor (5-HT2AR) agonist in 2014. The compound has since found extensive use as a pharmacological tool in a variety of in vivo and in vitro studies. In the present study, we present an improved and scalable synthesis of 25CN-NBOH making this compound readily available to the scientific community.",

author = "Emil Marcher-R{\o}rsted and Jitka Nykodemova and Kristensen, {Jesper Langgaard}",

year = "2021",

doi = "10.1055/a-1524-4439",

language = "English",

volume = "5",

pages = "158--160",

journal = "SynOpen",

issn = "2509-9396",

publisher = "Thieme Medical Publishers",

number = "2",

}

TY - JOUR

T1 - An improved, scalable synthesis of the selective serotonin 2A receptor agonist 25CN-NBOH

AU - Marcher-Rørsted, Emil

AU - Nykodemova, Jitka

AU - Kristensen, Jesper Langgaard

PY - 2021

Y1 - 2021

N2 - 4-{2-[(2-hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile (25CN-NBOH) was first reported as a potent and highly selective serotonin 2A receptor (5-HT2AR) agonist in 2014. The compound has since found extensive use as a pharmacological tool in a variety of in vivo and in vitro studies. In the present study, we present an improved and scalable synthesis of 25CN-NBOH making this compound readily available to the scientific community.

AB - 4-{2-[(2-hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile (25CN-NBOH) was first reported as a potent and highly selective serotonin 2A receptor (5-HT2AR) agonist in 2014. The compound has since found extensive use as a pharmacological tool in a variety of in vivo and in vitro studies. In the present study, we present an improved and scalable synthesis of 25CN-NBOH making this compound readily available to the scientific community.

U2 - 10.1055/a-1524-4439

DO - 10.1055/a-1524-4439

M3 - Journal article

SN - 2509-9396

VL - 5

SP - 158

EP - 160

JO - SynOpen

JF - SynOpen

IS - 2

ER -